1. Home
  2. HOWL vs TMQ Comparison

HOWL vs TMQ Comparison

Compare HOWL & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • TMQ
  • Stock Information
  • Founded
  • HOWL 2017
  • TMQ 2004
  • Country
  • HOWL United States
  • TMQ Canada
  • Employees
  • HOWL N/A
  • TMQ N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • HOWL Health Care
  • TMQ Basic Materials
  • Exchange
  • HOWL Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • HOWL 87.4M
  • TMQ 83.6M
  • IPO Year
  • HOWL 2021
  • TMQ N/A
  • Fundamental
  • Price
  • HOWL $1.36
  • TMQ $1.28
  • Analyst Decision
  • HOWL Strong Buy
  • TMQ
  • Analyst Count
  • HOWL 2
  • TMQ 0
  • Target Price
  • HOWL $9.50
  • TMQ N/A
  • AVG Volume (30 Days)
  • HOWL 263.3K
  • TMQ 339.8K
  • Earning Date
  • HOWL 03-06-2025
  • TMQ 04-02-2025
  • Dividend Yield
  • HOWL N/A
  • TMQ N/A
  • EPS Growth
  • HOWL N/A
  • TMQ N/A
  • EPS
  • HOWL N/A
  • TMQ N/A
  • Revenue
  • HOWL $3,386,000.00
  • TMQ N/A
  • Revenue This Year
  • HOWL N/A
  • TMQ N/A
  • Revenue Next Year
  • HOWL $34.17
  • TMQ N/A
  • P/E Ratio
  • HOWL N/A
  • TMQ N/A
  • Revenue Growth
  • HOWL N/A
  • TMQ N/A
  • 52 Week Low
  • HOWL $1.26
  • TMQ $0.25
  • 52 Week High
  • HOWL $8.19
  • TMQ $1.48
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • TMQ 56.43
  • Support Level
  • HOWL $1.26
  • TMQ $1.22
  • Resistance Level
  • HOWL $1.45
  • TMQ $1.38
  • Average True Range (ATR)
  • HOWL 0.09
  • TMQ 0.10
  • MACD
  • HOWL 0.02
  • TMQ -0.00
  • Stochastic Oscillator
  • HOWL 45.45
  • TMQ 54.05

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: